Home
>
National Drug Code (NDC)
>
ADVAIR
ADVAIR - 0173-0696-04 - (fluticasone propionate and salmeterol)
Drug Information of ADVAIR
| Product NDC: | 0173-0696 |
| Proprietary Name: | ADVAIR |
| Non Proprietary Name: | fluticasone propionate and salmeterol |
| Active Ingredient(s): | 250; 50 ug/1; ug/1 & nbsp; fluticasone propionate and salmeterol |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ADVAIR
| Product NDC: | 0173-0696 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021077 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010205 |
Package Information of ADVAIR
| Package NDC: | 0173-0696-04 |
| Package Description: | 14 POWDER in 1 INHALER (0173-0696-04) |
NDC Information of ADVAIR
| NDC Code | 0173-0696-04 |
| Proprietary Name | ADVAIR |
| Package Description | 14 POWDER in 1 INHALER (0173-0696-04) |
| Product NDC | 0173-0696 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluticasone propionate and salmeterol |
| Dosage Form Name | POWDER |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20010205 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
| Strength Number | 250; 50 |
| Strength Unit | ug/1; ug/1 |
| Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
